Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: N06AX21

Duloxetine Sandoz(duloxetine)

Anxiety Disorders;Neuralgia;Diabetes Mellitus;Depressive Disorder, Major

Marketing Authorisation Holder: Sandoz GmbH

INN: duloxetine

Indication

Treatment in adults of major depressive disorder, diabetic peripheral neuropathic pain and generalised anxiety disorder.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Duloxetine Sandoz — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.